pioglitazone has been researched along with Arthritis, Psoriatic in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Arthritis, Psoriatic: A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahara, M | 1 |
| Shiraiwa, T | 1 |
| Kaneto, H | 1 |
| Yasuda, T | 1 |
| Kuroda, A | 1 |
| Sakamoto, F | 1 |
| Naka, T | 1 |
| Miyashita, K | 1 |
| Sakamoto, K | 1 |
| Matsuoka, T | 1 |
| Shimomura, I | 1 |
| Matsuhisa, M | 1 |
| Bongartz, T | 1 |
| Coras, B | 1 |
| Vogt, T | 1 |
| Schölmerich, J | 1 |
| Müller-Ladner, U | 1 |
1 trial available for pioglitazone and Arthritis, Psoriatic
| Article | Year |
|---|---|
Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Drug The | 2005 |
1 other study available for pioglitazone and Arthritis, Psoriatic
| Article | Year |
|---|---|
Improvement of psoriatic arthritis by pioglitazone treatment in a type 2 diabetic patient.
Topics: Arthritis, Psoriatic; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Hu | 2010 |